Medical History, Medication Use, and Risk of Nasopharyngeal Carcinoma

Author:

Xiao Xiling1ORCID,Zhang Zhe1,Chang Ellen T23,Liu Zhiwei4,Liu Qing56,Cai Yonglin78,Chen Guomin9,Huang Qi-Hong10,Xie Shang-Hang56,Cao Su-Mei56,Shao Jian-Yong6,Jia Wei-Hua6,Zheng Yuming78,Liao Jian11,Chen Yufeng12,Lin Longde13,Ernberg Ingemar14,Huang Guangwu1,Zeng Yi6915,Zeng Yi-Xin615,Adami Hans-Olov1216,Ye Weimin12

Affiliation:

1. Department of Otolaryngology–Head and Neck Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China

2. Exponent, Inc., Center for Health Sciences, Menlo Park, California

3. Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California

4. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland

5. Department of Cancer Prevention Center, Sun Yat-sen University Cancer Center, Guangzhou, China

6. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China

7. Department of Clinical Laboratory, Wuzhou Red Cross Hospital, Wuzhou, China

8. Wuzhou Health System Key Laboratory for Nasopharyngeal Carcinoma Etiology and Molecular Mechanism, Wuzhou, China

9. State Key Laboratory for Infectious Diseases Prevention and Control, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China

10. Sihui Cancer Institute, Sihui, China

11. Cangwu Institute for Nasopharyngeal Carcinoma Control and Prevention, Wuzhou, China

12. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

13. Key Laboratory of High-Incidence Tumor Prevention and Treatment, Guangxi Medical University, Ministry of Education, Nanning, China

14. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

15. Beijing Hospital, Beijing, China

16. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

Funder

National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3